NAT10 and cholangiocarcinoma: Circular RNA circMAST1 competitively binds to NAT10 and obstructing NAT10-mediated ac4C modification on Yes-associated protein (YAP) mRNA, which accelerates YAP mRNA degradation and subsequently curtails tumor advancement in cholangiocarcinoma [136].